Indranil Nandi
18Patents
2h-index
44Co-inventors
54Inventor score
Filing activity: Jan 30, 2004 → Jan 15, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD851757S1 | Syringe | General | 22 | Active |
| USD836772S1 | Syringe | General | 17 | Active |
| US11020349B1 | Transmucosal dosage forms of remdesivir | Human Necessities | 1 | Active |
| US11642351B2 | Eslicarbazepine suspension | Human Necessities | 0 | Active |
| US11327065B1 | Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof | Physics | 0 | Active |
| US11331324B2 | Modified release suspension of eslicarbazepine | Human Necessities | 0 | Active |
| US12268547B2 | Imaging method for diagnosing cardiovascular disease | Physics | 0 | Active |
| US12102789B1 | Radiopharmaceutical delivery system and use thereof for patient infusion | Human Necessities | 0 | Active |
| US12417858B2 | Device to facilitate safe transport of medical radioisotope systems | Physics | 0 | Active |
| US11311518B1 | Parenteral dosage form of β3 adrenoreceptor agonists | Human Necessities | 0 | Active |
| US9989519B1 | Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (RLD) | Physics | 0 | Active |
| US10889549B2 | Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof | Performing Operations; Transporting | 0 | Active |
| US8168228B2 | Antibiotic clarithromycin micropellet compositions | Human Necessities | 0 | Active |
| US12226607B2 | Radiopharmaceutical delivery system and use thereof for patient infusion | Human Necessities | 0 | Active |
| US12390579B2 | Radiopharmaceutical delivery system for patient infusion | Human Necessities | 0 | Active |
| US11013702B2 | Midodrine hydrochloride oral solution and uses thereof | Human Necessities | 0 | Active |
| US11318145B2 | Eslicarbazepine suspension | Human Necessities | 0 | Active |
| US11583521B2 | Long-acting injection dosage form of beta 3 adrenoreceptor agonists | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.